Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bipolar Efficacy Biomarkers for Accelerated Intermittent Theta Burst rTMS Trial

NCT05393648 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT05393648
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05393648 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bipolar Efficacy Biomarkers for Accelerated Intermittent Theta Burst rTMS Trial
Lead sponsor
University of California, San Diego
Phase
Not applicable
Overall status
Unknown status
Start date
July 5, 2022
Completion date
December 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, bipolar disorder